# ComViKin

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/comvikin

- Industry: Biotechnology
- Headquarters: Huizhou, China
- Website: www.comvikin.com/
- Latest round: Series B (Mar 16, 2026)
- Investors on record: 10

## About

Based in Huizhou, China and founded in 2019, Huizhou Comvikin Biotechnology Co., Ltd., trading under the name ComViKin, provides biosynthetic ingredients for the biotechnology and food industries. The company established an ester enzymatic synthesis process platform to achieve environmentally friendly production. In product application, the company has established joint laboratories with Tsinghua University, Jiangnan University, and other research institutions. In March 2026, the firm raised a series B+ funding round from GTJA Innovation Investment, MPC and Dalton Venture.

The company works with enterprise clients across various industries to provide high-purity ingredients produced using biological enzymatic methods. Its core product is Ascorbyl Palmitate (AP), a fat-soluble antioxidant utilized in infant formula, cosmetics, and pharmaceutical preparations.

The company generates revenue from the direct sale of its biosynthetic ingredients to global enterprise clients.

The company plans to commercialize multiple new products through its technology platform, including enzymatically produced phytosterol esters, vitamin A palmitate, and ascorbyl oleate. The recent series B+ funding will be used to increase investment in research and development, production, and market expansion to accelerate its global operations.

## Funding rounds

- Series B, Mar 16, 2026 — GTJA Innovation Investment, MPC, Dalton Venture
- Series B, Sep 16, 2025 — CDH Investments, CoStone Capital, Guizhou Xijiu, Puhua Capital, Delian Capital, Orient Jiafu Asset Management, Dymatic Chemicals

## Investors

- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Series B
- CoStone Capital (https://capitalatlas.ai/funds/costone-capital) — Series B
- Guizhou Xijiu — Series B
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Series B
- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series B
- Orient Jiafu Asset Management (https://capitalatlas.ai/funds/orient-jiafu-asset-management) — Series B
- Dymatic Chemicals — Series B
- GTJA Innovation Investment (https://capitalatlas.ai/funds/gtja-innovation-investment) — Series B
- MPC — Series B
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series B